Walker Morris advises on the sale of YorkTest LaboratoriesPrint news article
A multi-disciplinary team at Walker Morris has advised the management team of leading food intolerance testing specialists, YorkTest Laboratories, on an investment by private equity investors, Key Capital Partners.
Based in York, YorkTest are Europe’s leading provider of food and drink specific lgG antibody testing. The company has over 35 years’ experience in laboratory diagnostic testing and provides customers with information to help optimise their diet and wellbeing.
This investment from Key Capital Partners will provide YorkTest with a solid platform for future growth and development and as part of the deal current private equity investors, CBPE Capital, will exit.
Walker Morris fielded a multi-disciplinary team comprising of John Hamer and Oliver Duke (corporate).
John Hamer, Corporate Partner, commented:
“We are delighted to advise the management team at YorkTest on this successful investment from Key Capital Partners which will allow the company to pursue its future growth strategy.
Our wealth of experience in private equity meant that we were able to guide the management team through the complex transaction and our tax specialists allowed us to maximise the tax efficiency of the transaction for the management team.”